Fact sheet: EDRFHlthcr

Fund information

Fund name
EDRF Healthcare R EUR
Fund company manager
Edmond de Rothschild Asset Man
Fund type
SIB
Fund manager(s)
Adeline Salat Baroux
since 01/01/2009
Valerie Guelfi
since 02/09/2016
Fund objective
The objective is to grow net assets by investing in companies operating in the healthcare sector, over the recommended investment period.
Benchmark
MSCI AC World Health Care
Investment style
None
Investment method
Shares

Performance snapshot

Sector
Fund
Sector
Fund
Sector
Fund

Quick stats

1 Year return

-5.51 %

1 Year rank in sector

29/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 373.4 m

FE Risk score

161

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • North America
    71.4%
  • Europe
    25.4%
  • Asia Pacific ex Japan
    2.8%
  • Money Market
    0.4%
  • Biotechnology/Medical
    43.6%
  • Pharmaceuticals
    35.2%
  • Healthcare & Medical Products
    11.6%
  • Health Care
    9.2%
  • Money Market
    0.4%
  • North American Equities
    71.4%
  • European Equities
    25.4%
  • Asia Pacific ex Japan Equities
    2.8%
  • Money Market
    0.4%

Performance vs. Sector

Sector
Fund
Sector
Fund
Sector
Fund

Cumulative performance

1m6m1y3y5y
Fund1.23 %-8.11 %-5.51 %8.8 %78.04 %
Sector2.06 %1.96 %13.65 %12.92 %95.86 %
Rank within sector21 / 3030 / 3029 / 2915 / 2617 / 22
Quartile th3 rd4 th4 th3 rd4 th

Calendar performance

YTD-20172016201520142013
Fund-4.33 %-8.06 %19.28 %36.28 %26.28 %
Sector13.89 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector29 / 2913 / 292 / 267 / 2321 / 22
Quartile th4 th2 nd1 st2 nd4 th

Risk statistics

Alpha-0.82
Beta0.96
Sharpe-0
Volatility16.51
Tracking error7.7
Information ratio-0.15
R-Squared0.79

Price movement

52 week high336.21
52 week low290.74
Current bid price0
Current offer price0
Current mid price294.61

Holdings by region

  • 71.4% North America
  • 25.4% Europe
  • 2.8% Asia Pacific ex Japan
  • 0.4% Money Market

Holdings by sector

  • 43.6% Biotechnology/Medical
  • 35.2% Pharmaceuticals
  • 11.6% Healthcare & Medical Products
  • 9.2% Health Care
  • 0.4% Money Market

Holdings by asset type

  • 71.4% North American Equities
  • 25.4% European Equities
  • 2.8% Asia Pacific ex Japan Equities
  • 0.4% Money Market

Individual holdings

  • 5.9% ALLERGAN PLC
  • 5.9% CELGENE CORP
  • 5.7% GILEAD SCIENCES INC
  • 4.9% ASTRAZENECA PLC
  • 4.5% SHIRE PLC